Skip to content

Evaluate the utility of VEXUS score as a marker for acute kindey injury in patients of septic shock.

Evaluation of VEXUS score as a marker for acute kidney injury in patients of septic shock. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/03/083686
Enrollment
82
Registered
2025-03-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N178- Other acute kidney failure

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Max superspeciality hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: -Patients who fulfil the septic shock definition according to the Sepsis-3 consensus conference.

Exclusion criteria

Exclusion criteria: -Patient s refusal to participate. -Patients in which more than 4 hours have elapsed since diagnosis of septic shock. -Anticipated to undergo immediate surgery. -Hemodynamic instability due to active haemorrhage. -Patients with previously known conditions that interfere with Doppler assessments, namely liver cirrhosis. Pregnancy Chronic Kidney Disease (CKD) patients on Haemodialysis

Design outcomes

Primary

MeasureTime frame
1.Evaluation of utility of VEXUS score as a marker for acute kidney injury in patients with septic shock. Timepoint: Will be observed till patient is admitted in intensive care unit.

Secondary

MeasureTime frame
1.Correlation of VEXUS score with need of renal replacement therapy in sepsis patients. 2.Correlation of VEXUS score with intensive care unit mortality. 3.Need of renal replacement therapy in sepsis induced acute kidney injury patients. 4.Duration of intensive care unit stay. Timepoint: Will be observed till patient is admitted in intensive care unit.

Countries

India

Contacts

Public ContactDr. Omender Singh

Max super-speciality hospital, Saket, New Delhi

Omender.Singh@maxhealthcare.com9810734246

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026